BDX Filing
4Filing Date: Jun 25, 2026
BECTON DICKINSON & CO (BDX) · Insider Trading (Form 4) SEC Filing
Statement of Changes in Beneficial Ownership
descriptionView SEC Filing
ACC: 0001628280-26-045374open_in_new
Total Value$160.2K
Trades1
Insiders1
Transaction Details
Garrison Michael David
EVP & Pres Med.Essntl&BioPharm·Direct
Sell · Dispose
Common Stock
Shares-1.10K
Price$145.66
Total Value$160.2K
Shares Owned After13.17K
Transaction DateJun 24, 2026
10b5-1
Post-Transaction Holdings
Garrison Michael David
| Security | Shares | Change |
|---|---|---|
| Common Stock | 13.17K | -1.10K (-7.71%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-06-24
10b5-1 Pre-arranged Plan: Yes
--- Issuer ---
Name: BECTON DICKINSON & CO (BDX)
CIK: 0000010795
--- Reporting Owner ---
Name: Garrison Michael David
CIK: 0001944816
Role: Officer (EVP & Pres Med.Essntl&BioPharm)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-06-24 | Code: S (Open market sale)
Shares: -1,100 | Price: $145.66
Total Value: $160,226.00
Shares Owned After: 13,172 | Ownership: D (Direct)
--- Signature ---
/s/ Donna Kalazdy, by power of attorney from Michael David Garrison (2026-06-25)